Pilot testing of dipsticks as point-of-care assays for rapid diagnosis of poor-quality artemisinin drugs in endemic settings
Open Access
- 16 May 2016
- journal article
- research article
- Published by Springer Nature in Tropical Medicine and Health
- Vol. 44 (1) , 15
Abstract
Good-quality artemisinin drugs are essential for malaria treatment, but increasing prevalence of poor-quality artemisinin drugs in many endemic countries hinders effective management of malaria cases. To develop a point-of-care assay for rapid identification of counterfeit and substandard artemisinin drugs for resource-limited areas, we used specific monoclonal antibodies against artesunate and artemether, and developed prototypes of lateral flow dipstick assays. In this pilot test, we evaluated the feasibility of these dipsticks under different endemic settings and their performance in the hands of untrained personnel. The results showed that the dipstick tests can be successfully performed by different investigators with the included instruction sheet. None of the artemether and artesunate drugs collected from public pharmacies in different endemic countries failed the test. It is possible that the simple dipstick assays, with future optimization of test conditions and sensitivity, can be used as a qualitative and semi-quantitative assay for rapid screening of counterfeit artemisinin drugs in endemic settings.Keywords
Funding Information
- National Institutes of Health (U19AI089672)
This publication has 13 references indexed in Scilit:
- Malaria Diagnosis Across the International Centers of Excellence for Malaria Research: Platforms, Performance, and StandardizationThe American Journal of Tropical Medicine and Hygiene, 2015
- Integration of Novel Low-Cost Colorimetric, Laser Photometric, and Visual Fluorescent Techniques for Rapid Identification of Falsified Medicines in Resource-Poor Areas: Application to Artemether–LumefantrineThe American Journal of Tropical Medicine and Hygiene, 2015
- Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan AfricaThe American Journal of Tropical Medicine and Hygiene, 2015
- The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidenceMalaria Journal, 2014
- Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisininMalaria Journal, 2014
- Validation of ELISA for Quantitation of Artemisinin-Based Antimalarial DrugsThe American Journal of Tropical Medicine and Hygiene, 2013
- Development of a Specific Monoclonal Antibody-Based ELISA to Measure the Artemether Content of Antimalarial DrugsPLOS ONE, 2013
- Poor-quality antimalarial drugs in southeast Asia and sub-Saharan AfricaThe Lancet Infectious Diseases, 2012
- Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric methodTropical Medicine & International Health, 2001
- A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunateJournal of Pharmaceutical and Biomedical Analysis, 2000